Conmed Corp. Aktie News

CONMED Corporation ( CNMD ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Patrick Beyer - President, CEO & Director Todd Garner - Executive VP of Finance & CFO Conference Call Participants Lilia-Celine Lozada - JPMorgan Chase & Co, Research Division Anna Runci - Piper Sandler & Co., Research Division Vikramjeet Chopra - Wells Fargo Securities, LLC, Research Division Yo...

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Sales of $337.9 million increased 6.7% year-over-year as reported and 6.3% in constant currency. Domestic revenue increased 5.9% year-over-year. International revenue increased 7.8% year-over-year as reported and 6.8% in co...

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2025 after the market close on Wednesday, November 5, 2025. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and o...

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Kim Kelderman will be joining its Board of Directors effective September 8, 2025. “My fellow directors and I are delighted to welcome Kim to the board,” said LaVerne Council, Chair of CONMED's Board of Directors. “Kim brings extensive global leadership experience across life sciences businesses, with a strong tra...

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors declared a quarterly cash dividend of $0.20 per share on August 7, 2025, payable on October 3, 2025, to all shareholders of record as of September 15, 2025. About CONMED Corporation CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Compa...

Conmed (CNMD) Q2 EPS Jumps 17%

CONMED Corporation (NYSE:CNMD ) Q2 2025 Earnings Conference Call July 30, 2025 4:30 PM ET Company Participants Patrick J. Beyer - President, CEO & Director Todd W.

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Sales of $342.3 million increased 3.1% year-over-year as reported and 2.9% in constant currency. Domestic revenue increased 2.8% year-over-year. International revenue increased 3.4% year-over-year as reported and 2.9% in const...